U.S. Health Secretary Vows Aid To India In Setting Up FDA Version (India)
This article was originally published in PharmAsia News
U.S. Health and Human Services Secretary Michael Leavitt said during a visit to India that the United States plans to provide technical assistance to develop a Center for Food and Drug Administration in the country. Leavitt explained that the intention is to augment India's effort to develop and equip an FDA similar to that of the U.S. He said his counterpart, Union Health Minister Anbumani Ramadoss, indicated India wanted technical advice from the United States. Leavitt also said the U.S. is interested in having an FDA liaison office in India. (Click here for more
You may also be interested in...
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?
Lorbrena is approved as a second-line treatment for ALK-positive NSCLC but Pfizer believes data from the first-line Phase III CROWN study makes the drug a serious competitor to standard of care Alecensa in the first-line setting.